

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | daunorubicin metabolic process (GO:0044597) | 6.31925205 |
| 2 | polyketide metabolic process (GO:0030638) | 6.31925205 |
| 3 | doxorubicin metabolic process (GO:0044598) | 6.31925205 |
| 4 | histone H4-K5 acetylation (GO:0043981) | 4.71908151 |
| 5 | histone H4-K8 acetylation (GO:0043982) | 4.71908151 |
| 6 | interkinetic nuclear migration (GO:0022027) | 4.55216438 |
| 7 | histone H4-K12 acetylation (GO:0043983) | 4.40928638 |
| 8 | proline transport (GO:0015824) | 4.36694807 |
| 9 | maintenance of protein location in nucleus (GO:0051457) | 4.19138799 |
| 10 | histone H3-K36 demethylation (GO:0070544) | 4.09789327 |
| 11 | pre-miRNA processing (GO:0031054) | 4.08184012 |
| 12 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.05757233 |
| 13 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.99893054 |
| 14 | somite rostral/caudal axis specification (GO:0032525) | 3.99059549 |
| 15 | coenzyme catabolic process (GO:0009109) | 3.94364757 |
| 16 | histone H3-K9 demethylation (GO:0033169) | 3.94042389 |
| 17 | histone H4-K16 acetylation (GO:0043984) | 3.89428173 |
| 18 | mitochondrion distribution (GO:0048311) | 3.81606988 |
| 19 | protein targeting to Golgi (GO:0000042) | 3.77843361 |
| 20 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.75888031 |
| 21 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.74403850 |
| 22 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.70498836 |
| 23 | nuclear pore complex assembly (GO:0051292) | 3.67416831 |
| 24 | regulation of ARF protein signal transduction (GO:0032012) | 3.66900847 |
| 25 | synaptic vesicle maturation (GO:0016188) | 3.62328410 |
| 26 | Golgi to endosome transport (GO:0006895) | 3.56864039 |
| 27 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.49998030 |
| 28 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.46720210 |
| 29 | nucleus localization (GO:0051647) | 3.46386178 |
| 30 | cerebellar granule cell differentiation (GO:0021707) | 3.42572332 |
| 31 | establishment of protein localization to Golgi (GO:0072600) | 3.40589983 |
| 32 | regulation of response to osmotic stress (GO:0047484) | 3.39928651 |
| 33 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.38754761 |
| 34 | positive regulation of histone deacetylation (GO:0031065) | 3.37741755 |
| 35 | nuclear pore organization (GO:0006999) | 3.34329523 |
| 36 | histone H3-K4 methylation (GO:0051568) | 3.34086716 |
| 37 | stress granule assembly (GO:0034063) | 3.31299862 |
| 38 | mitotic sister chromatid segregation (GO:0000070) | 3.22662168 |
| 39 | glutamate secretion (GO:0014047) | 3.22128589 |
| 40 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.20567439 |
| 41 | histone lysine demethylation (GO:0070076) | 3.19994649 |
| 42 | cellular response to ethanol (GO:0071361) | 3.19981274 |
| 43 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.19694614 |
| 44 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.14865944 |
| 45 | hormone catabolic process (GO:0042447) | 3.12990482 |
| 46 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.09663052 |
| 47 | histone demethylation (GO:0016577) | 3.08810340 |
| 48 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.08413125 |
| 49 | establishment of nucleus localization (GO:0040023) | 3.06363774 |
| 50 | cellular modified amino acid catabolic process (GO:0042219) | 3.02085067 |
| 51 | peptidyl-threonine phosphorylation (GO:0018107) | 2.99320660 |
| 52 | regulation of histone H3-K27 methylation (GO:0061085) | 2.99040063 |
| 53 | sister chromatid segregation (GO:0000819) | 2.98029881 |
| 54 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.97732161 |
| 55 | mitochondrion localization (GO:0051646) | 2.96943104 |
| 56 | striatum development (GO:0021756) | 2.94241203 |
| 57 | peptidyl-threonine modification (GO:0018210) | 2.93787676 |
| 58 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.91236167 |
| 59 | regulation of RNA export from nucleus (GO:0046831) | 2.90124439 |
| 60 | protein localization to kinetochore (GO:0034501) | 2.89928261 |
| 61 | lipid translocation (GO:0034204) | 2.88292160 |
| 62 | phospholipid translocation (GO:0045332) | 2.88292160 |
| 63 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.88181441 |
| 64 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.85061722 |
| 65 | regulation of cilium movement (GO:0003352) | 2.83623185 |
| 66 | heterochromatin organization (GO:0070828) | 2.82841815 |
| 67 | macroautophagy (GO:0016236) | 2.82418351 |
| 68 | chromatin assembly (GO:0031497) | 2.81389936 |
| 69 | negative regulation of telomerase activity (GO:0051974) | 2.79766813 |
| 70 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.79574846 |
| 71 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.77016590 |
| 72 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.75157591 |
| 73 | positive regulation of synapse maturation (GO:0090129) | 2.74943299 |
| 74 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.73243707 |
| 75 | response to dietary excess (GO:0002021) | 2.71584428 |
| 76 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.71097408 |
| 77 | histone H3-K4 trimethylation (GO:0080182) | 2.70294019 |
| 78 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.70023675 |
| 79 | protein K48-linked deubiquitination (GO:0071108) | 2.69870192 |
| 80 | phenol-containing compound catabolic process (GO:0019336) | 2.69500981 |
| 81 | definitive hemopoiesis (GO:0060216) | 2.69130688 |
| 82 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.68766447 |
| 83 | positive regulation of protein deacetylation (GO:0090312) | 2.67950751 |
| 84 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.67235908 |
| 85 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.66762950 |
| 86 | NLS-bearing protein import into nucleus (GO:0006607) | 2.65946770 |
| 87 | regulation of telomere maintenance (GO:0032204) | 2.65032106 |
| 88 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.64727071 |
| 89 | pore complex assembly (GO:0046931) | 2.64237563 |
| 90 | protein dealkylation (GO:0008214) | 2.63403514 |
| 91 | protein demethylation (GO:0006482) | 2.63403514 |
| 92 | rRNA transcription (GO:0009303) | 2.62039538 |
| 93 | neurotransmitter secretion (GO:0007269) | 2.60846856 |
| 94 | ventricular system development (GO:0021591) | 2.60360720 |
| 95 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.59714199 |
| 96 | receptor recycling (GO:0001881) | 2.57037525 |
| 97 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.55627341 |
| 98 | intestinal epithelial cell development (GO:0060576) | 2.55383627 |
| 99 | muscle organ morphogenesis (GO:0048644) | 2.55087313 |
| 100 | peptidyl-lysine trimethylation (GO:0018023) | 2.52695943 |
| 101 | protein polyglutamylation (GO:0018095) | 2.51932485 |
| 102 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.51901376 |
| 103 | vocalization behavior (GO:0071625) | 2.51531308 |
| 104 | mitochondrion transport along microtubule (GO:0047497) | 2.51077851 |
| 105 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.51077851 |
| 106 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.50392778 |
| 107 | vesicle transport along microtubule (GO:0047496) | 2.49155543 |
| 108 | positive regulation of Rap GTPase activity (GO:0032854) | 2.47886325 |
| 109 | L-amino acid import (GO:0043092) | 2.47514401 |
| 110 | negative regulation of histone methylation (GO:0031061) | 2.47033251 |
| 111 | epoxygenase P450 pathway (GO:0019373) | 2.46871307 |
| 112 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.46520587 |
| 113 | synaptic vesicle exocytosis (GO:0016079) | 2.45706365 |
| 114 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.44961518 |
| 115 | negative regulation of inclusion body assembly (GO:0090084) | 2.44885301 |
| 116 | cerebral cortex development (GO:0021987) | 2.41901308 |
| 117 | tachykinin receptor signaling pathway (GO:0007217) | 2.41425054 |
| 118 | locomotory exploration behavior (GO:0035641) | 2.40908803 |
| 119 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.40851783 |
| 120 | negative regulation of epidermis development (GO:0045683) | 2.38601604 |
| 121 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.37000685 |
| 122 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.36887826 |
| 123 | cell migration in hindbrain (GO:0021535) | 2.35737464 |
| 124 | cell differentiation in hindbrain (GO:0021533) | 2.34383073 |
| 125 | establishment of mitochondrion localization (GO:0051654) | 2.34078002 |
| 126 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.33910388 |
| 127 | growth hormone receptor signaling pathway (GO:0060396) | 2.33278346 |
| 128 | regulation of Rap GTPase activity (GO:0032317) | 2.33196664 |
| 129 | histone lysine methylation (GO:0034968) | 2.31362448 |
| 130 | glycolytic process (GO:0006096) | 2.30813922 |
| 131 | protein localization to cilium (GO:0061512) | 2.30089175 |
| 132 | regulation of protein polyubiquitination (GO:1902914) | 2.29920971 |
| 133 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.29422952 |
| 134 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.28787491 |
| 135 | regulation of synaptic vesicle transport (GO:1902803) | 2.28171362 |
| 136 | apical protein localization (GO:0045176) | 2.27961345 |
| 137 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.26673179 |
| 138 | RNA stabilization (GO:0043489) | 2.26063180 |
| 139 | mRNA stabilization (GO:0048255) | 2.26063180 |
| 140 | detection of temperature stimulus (GO:0016048) | 2.26052723 |
| 141 | transepithelial transport (GO:0070633) | 2.25652888 |
| 142 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.25480777 |
| 143 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.25217559 |
| 144 | early endosome to late endosome transport (GO:0045022) | 2.25016938 |
| 145 | cytidine catabolic process (GO:0006216) | 2.24774463 |
| 146 | microtubule nucleation (GO:0007020) | 2.22946830 |
| 147 | myoblast fusion (GO:0007520) | 2.20550797 |
| 148 | regulation of establishment of cell polarity (GO:2000114) | 2.20194498 |
| 149 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.19732049 |
| 150 | cellular response to epinephrine stimulus (GO:0071872) | 2.19690279 |
| 151 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.19385785 |
| 152 | regulation of Rac protein signal transduction (GO:0035020) | 2.18959333 |
| 153 | phospholipid dephosphorylation (GO:0046839) | 2.16306602 |
| 154 | cellular response to growth hormone stimulus (GO:0071378) | 2.14750078 |
| 155 | peptidyl-serine phosphorylation (GO:0018105) | 2.14701580 |
| 156 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.14145592 |
| 157 | regulation of ARF GTPase activity (GO:0032312) | 2.13573894 |
| 158 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.11926226 |
| 159 | hypotonic response (GO:0006971) | 2.11354544 |
| 160 | positive regulation of granulocyte differentiation (GO:0030854) | 2.11194377 |
| 161 | mannose metabolic process (GO:0006013) | 2.10374606 |
| 162 | embryonic process involved in female pregnancy (GO:0060136) | 2.08422663 |
| 163 | phosphatidylinositol phosphorylation (GO:0046854) | 2.07186627 |
| 164 | histone H3-K9 modification (GO:0061647) | 2.06647568 |
| 165 | peptidyl-lysine methylation (GO:0018022) | 2.06339128 |
| 166 | nucleus organization (GO:0006997) | 2.05695973 |
| 167 | mitotic sister chromatid cohesion (GO:0007064) | 2.05449371 |
| 168 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.04771917 |
| 169 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.04123233 |
| 170 | oocyte development (GO:0048599) | 2.03743574 |
| 171 | negative regulation of fatty acid transport (GO:2000192) | 2.03124679 |
| 172 | regulation of gamma-delta T cell activation (GO:0046643) | 2.02299470 |
| 173 | COPII vesicle coating (GO:0048208) | 2.01915297 |
| 174 | nerve growth factor signaling pathway (GO:0038180) | 2.01335411 |
| 175 | response to epinephrine (GO:0071871) | 1.99900433 |
| 176 | peptidyl-serine modification (GO:0018209) | 1.99551215 |
| 177 | embryonic eye morphogenesis (GO:0048048) | 1.97614517 |
| 178 | positive regulation of Rab GTPase activity (GO:0032851) | 1.97095806 |
| 179 | regulation of Rab GTPase activity (GO:0032313) | 1.97095806 |
| 180 | negative regulation of cell killing (GO:0031342) | 1.96034595 |
| 181 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 1.96034595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.57007546 |
| 2 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.57007546 |
| 3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.57007546 |
| 4 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.64667509 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.28533460 |
| 6 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 3.17275555 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.03204771 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.94057042 |
| 9 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.57460723 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.42188119 |
| 11 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.34578041 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.29585113 |
| 13 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.27603970 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.21345704 |
| 15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.21296234 |
| 16 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.15720480 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.14335988 |
| 18 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 2.13789379 |
| 19 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.08717694 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.01201440 |
| 21 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.97843478 |
| 22 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.96950903 |
| 23 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.96347359 |
| 24 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.96329714 |
| 25 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.93907425 |
| 26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.87793339 |
| 27 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.86267172 |
| 28 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.84792771 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.83630671 |
| 30 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.76326015 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.76180130 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75803291 |
| 33 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.74618749 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.67874064 |
| 35 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.65901971 |
| 36 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.63340567 |
| 37 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.60979765 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.60795472 |
| 39 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.59843673 |
| 40 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.58988678 |
| 41 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.58213754 |
| 42 | STAT3_23295773_ChIP-Seq_U87_Human | 1.56210892 |
| 43 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.55633704 |
| 44 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.55327501 |
| 45 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.54355258 |
| 46 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.53079811 |
| 47 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.50389473 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49830852 |
| 49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49290333 |
| 50 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.47652946 |
| 51 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.47599964 |
| 52 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.45761425 |
| 53 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.45594416 |
| 54 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.43360528 |
| 55 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.42188719 |
| 56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.41643739 |
| 57 | AR_19668381_ChIP-Seq_PC3_Human | 1.41408555 |
| 58 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.38410735 |
| 59 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.37596275 |
| 60 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36531182 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.36435326 |
| 62 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.36069526 |
| 63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.35754795 |
| 64 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.35585499 |
| 65 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.34773958 |
| 66 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.29784321 |
| 67 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.29490183 |
| 68 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.29477484 |
| 69 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27792798 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27733140 |
| 71 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.27484109 |
| 72 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27326970 |
| 73 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.26791113 |
| 74 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.25769985 |
| 75 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.22877075 |
| 76 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.22005096 |
| 77 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.21593074 |
| 78 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21156653 |
| 79 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.20681432 |
| 80 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.20574218 |
| 81 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.20101454 |
| 82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19796483 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18548744 |
| 84 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18299591 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17840594 |
| 86 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.17022160 |
| 87 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16314053 |
| 88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14962875 |
| 89 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.14414978 |
| 90 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.13949055 |
| 91 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.13834517 |
| 92 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13119302 |
| 93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12506541 |
| 94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11775966 |
| 95 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.11600323 |
| 96 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.11539982 |
| 97 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.11247356 |
| 98 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.10889806 |
| 99 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10502209 |
| 100 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.10090907 |
| 101 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09874110 |
| 102 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09753213 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08856278 |
| 104 | GATA2_19941826_ChIP-Seq_K562_Human | 1.07208737 |
| 105 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06865692 |
| 106 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06767139 |
| 107 | MYC_22102868_ChIP-Seq_BL_Human | 1.06664806 |
| 108 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06585066 |
| 109 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06584181 |
| 110 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.04862412 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04800150 |
| 112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04000048 |
| 113 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03650701 |
| 114 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03498519 |
| 115 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02724386 |
| 116 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02655916 |
| 117 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.01620132 |
| 118 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.01115374 |
| 119 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00291646 |
| 120 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.00250439 |
| 121 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.97658371 |
| 122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97464643 |
| 123 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97222285 |
| 124 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96401176 |
| 125 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96401176 |
| 126 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96114386 |
| 127 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95785214 |
| 128 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95603696 |
| 129 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95531941 |
| 130 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.95463335 |
| 131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95317296 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95317296 |
| 133 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95069083 |
| 134 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.95031188 |
| 135 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94919284 |
| 136 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94648102 |
| 137 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94502350 |
| 138 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94342912 |
| 139 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94022446 |
| 140 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.93726425 |
| 141 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93712341 |
| 142 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.93431403 |
| 143 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92950422 |
| 144 | * STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.92304134 |
| 145 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92221397 |
| 146 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92170584 |
| 147 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.91664666 |
| 148 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91287366 |
| 149 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.91027865 |
| 150 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.89237467 |
| 151 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.89083288 |
| 152 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88868502 |
| 153 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.88692495 |
| 154 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88523830 |
| 155 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.87313044 |
| 156 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87267845 |
| 157 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.86767634 |
| 158 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.85295717 |
| 159 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85152569 |
| 160 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.84782844 |
| 161 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.84203630 |
| 162 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.83214865 |
| 163 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82809292 |
| 164 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82731880 |
| 165 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.82350858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002009_preneoplasia | 4.30118630 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 3.36638441 |
| 3 | MP0003122_maternal_imprinting | 3.20848469 |
| 4 | MP0003787_abnormal_imprinting | 3.10565272 |
| 5 | MP0003890_abnormal_embryonic-extraembry | 3.05883729 |
| 6 | MP0005394_taste/olfaction_phenotype | 2.90094964 |
| 7 | MP0005499_abnormal_olfactory_system | 2.90094964 |
| 8 | MP0005409_darkened_coat_color | 2.78638476 |
| 9 | MP0004858_abnormal_nervous_system | 2.67935973 |
| 10 | MP0003121_genomic_imprinting | 2.67693910 |
| 11 | MP0009046_muscle_twitch | 2.51551445 |
| 12 | MP0002653_abnormal_ependyma_morphology | 2.42452971 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.32139596 |
| 14 | MP0000569_abnormal_digit_pigmentation | 2.28931213 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.24675523 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.20349145 |
| 17 | MP0004036_abnormal_muscle_relaxation | 2.20236970 |
| 18 | MP0004130_abnormal_muscle_cell | 2.11195785 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.09955901 |
| 20 | MP0004859_abnormal_synaptic_plasticity | 2.08104881 |
| 21 | MP0008057_abnormal_DNA_replication | 2.03064329 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.01048776 |
| 23 | MP0005076_abnormal_cell_differentiation | 2.00020742 |
| 24 | MP0003011_delayed_dark_adaptation | 1.96681337 |
| 25 | MP0008961_abnormal_basal_metabolism | 1.96502495 |
| 26 | MP0002332_abnormal_exercise_endurance | 1.96182350 |
| 27 | MP0006035_abnormal_mitochondrial_morpho | 1.95655692 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.85250502 |
| 29 | MP0006292_abnormal_olfactory_placode | 1.84798318 |
| 30 | MP0005275_abnormal_skin_tensile | 1.84241774 |
| 31 | MP0004084_abnormal_cardiac_muscle | 1.84017548 |
| 32 | MP0003635_abnormal_synaptic_transmissio | 1.81266966 |
| 33 | MP0003690_abnormal_glial_cell | 1.80807218 |
| 34 | MP0003646_muscle_fatigue | 1.77519653 |
| 35 | MP0003091_abnormal_cell_migration | 1.70959347 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 1.70729125 |
| 37 | MP0010678_abnormal_skin_adnexa | 1.68064896 |
| 38 | MP0001486_abnormal_startle_reflex | 1.67110746 |
| 39 | MP0002254_reproductive_system_inflammat | 1.67055578 |
| 40 | MP0004270_analgesia | 1.64725323 |
| 41 | MP0004885_abnormal_endolymph | 1.64620294 |
| 42 | MP0002064_seizures | 1.62619968 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.62598522 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.57035786 |
| 45 | MP0000383_abnormal_hair_follicle | 1.55428703 |
| 46 | MP0004043_abnormal_pH_regulation | 1.51471548 |
| 47 | MP0002063_abnormal_learning/memory/cond | 1.51036222 |
| 48 | MP0000733_abnormal_muscle_development | 1.45188175 |
| 49 | MP0005257_abnormal_intraocular_pressure | 1.41630527 |
| 50 | MP0009703_decreased_birth_body | 1.38783390 |
| 51 | MP0008872_abnormal_physiological_respon | 1.37690796 |
| 52 | MP0001984_abnormal_olfaction | 1.35677698 |
| 53 | MP0004808_abnormal_hematopoietic_stem | 1.35246691 |
| 54 | MP0005380_embryogenesis_phenotype | 1.35072409 |
| 55 | MP0001672_abnormal_embryogenesis/_devel | 1.35072409 |
| 56 | MP0009745_abnormal_behavioral_response | 1.33398072 |
| 57 | MP0002006_tumorigenesis | 1.32634000 |
| 58 | MP0002088_abnormal_embryonic_growth/wei | 1.31099614 |
| 59 | MP0003984_embryonic_growth_retardation | 1.30992842 |
| 60 | MP0005451_abnormal_body_composition | 1.29907441 |
| 61 | MP0009115_abnormal_fat_cell | 1.29307470 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 1.26885126 |
| 63 | MP0003123_paternal_imprinting | 1.23980658 |
| 64 | MP0003868_abnormal_feces_composition | 1.22840959 |
| 65 | MP0002971_abnormal_brown_adipose | 1.21882205 |
| 66 | MP0001958_emphysema | 1.20519002 |
| 67 | MP0001851_eye_inflammation | 1.17305491 |
| 68 | MP0002272_abnormal_nervous_system | 1.15060360 |
| 69 | MP0008877_abnormal_DNA_methylation | 1.14114622 |
| 70 | MP0002877_abnormal_melanocyte_morpholog | 1.13037078 |
| 71 | MP0006138_congestive_heart_failure | 1.12866937 |
| 72 | MP0001440_abnormal_grooming_behavior | 1.12530900 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 1.12175457 |
| 74 | MP0005666_abnormal_adipose_tissue | 1.11262474 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 1.10815420 |
| 76 | MP0003828_pulmonary_edema | 1.09867878 |
| 77 | MP0004484_altered_response_of | 1.08328700 |
| 78 | MP0002127_abnormal_cardiovascular_syste | 1.08280882 |
| 79 | MP0010368_abnormal_lymphatic_system | 1.07510747 |
| 80 | MP0002734_abnormal_mechanical_nocicepti | 1.07420669 |
| 81 | MP0002909_abnormal_adrenal_gland | 1.07366698 |
| 82 | MP0002822_catalepsy | 1.04868685 |
| 83 | MP0000955_abnormal_spinal_cord | 1.04138402 |
| 84 | MP0002067_abnormal_sensory_capabilities | 1.02117706 |
| 85 | MP0004924_abnormal_behavior | 1.01820945 |
| 86 | MP0005386_behavior/neurological_phenoty | 1.01820945 |
| 87 | MP0004142_abnormal_muscle_tone | 1.01641609 |
| 88 | MP0009672_abnormal_birth_weight | 0.99686032 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.99169855 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 0.98071240 |
| 91 | MP0003119_abnormal_digestive_system | 0.97200948 |
| 92 | MP0002108_abnormal_muscle_morphology | 0.96818725 |
| 93 | MP0002229_neurodegeneration | 0.96733955 |
| 94 | MP0002086_abnormal_extraembryonic_tissu | 0.95877932 |
| 95 | MP0002970_abnormal_white_adipose | 0.95853228 |
| 96 | MP0002084_abnormal_developmental_patter | 0.95339427 |
| 97 | MP0001177_atelectasis | 0.94465579 |
| 98 | MP0004197_abnormal_fetal_growth/weight/ | 0.94429192 |
| 99 | MP0001348_abnormal_lacrimal_gland | 0.91054142 |
| 100 | MP0001270_distended_abdomen | 0.90981048 |
| 101 | MP0002269_muscular_atrophy | 0.90022253 |
| 102 | MP0003300_gastrointestinal_ulcer | 0.89206766 |
| 103 | MP0004233_abnormal_muscle_weight | 0.87834127 |
| 104 | MP0003935_abnormal_craniofacial_develop | 0.87597448 |
| 105 | MP0005266_abnormal_metabolism | 0.87213947 |
| 106 | MP0000759_abnormal_skeletal_muscle | 0.87000464 |
| 107 | MP0000428_abnormal_craniofacial_morphol | 0.86984573 |
| 108 | MP0005646_abnormal_pituitary_gland | 0.86882981 |
| 109 | MP0008569_lethality_at_weaning | 0.86668276 |
| 110 | MP0008770_decreased_survivor_rate | 0.86525642 |
| 111 | MP0003861_abnormal_nervous_system | 0.86489065 |
| 112 | MP0002184_abnormal_innervation | 0.85745984 |
| 113 | MP0003566_abnormal_cell_adhesion | 0.85579131 |
| 114 | MP0004087_abnormal_muscle_fiber | 0.85511732 |
| 115 | MP0001661_extended_life_span | 0.85472078 |
| 116 | MP0000703_abnormal_thymus_morphology | 0.85441493 |
| 117 | MP0010307_abnormal_tumor_latency | 0.84556942 |
| 118 | MP0002882_abnormal_neuron_morphology | 0.83991211 |
| 119 | MP0003632_abnormal_nervous_system | 0.83733961 |
| 120 | MP0003045_fibrosis | 0.83722155 |
| 121 | MP0002133_abnormal_respiratory_system | 0.83394238 |
| 122 | MP0005388_respiratory_system_phenotype | 0.83394238 |
| 123 | MP0003880_abnormal_central_pattern | 0.83359257 |
| 124 | MP0000350_abnormal_cell_proliferation | 0.83143639 |
| 125 | MP0001324_abnormal_eye_pigmentation | 0.82346760 |
| 126 | MP0000920_abnormal_myelination | 0.81755971 |
| 127 | MP0004085_abnormal_heartbeat | 0.81610715 |
| 128 | MP0003283_abnormal_digestive_organ | 0.81352262 |
| 129 | MP0004811_abnormal_neuron_physiology | 0.81051804 |
| 130 | MP0005375_adipose_tissue_phenotype | 0.80792962 |
| 131 | MP0003191_abnormal_cellular_cholesterol | 0.80734024 |
| 132 | MP0002152_abnormal_brain_morphology | 0.80543463 |
| 133 | MP0002114_abnormal_axial_skeleton | 0.80248586 |
| 134 | MP0010630_abnormal_cardiac_muscle | 0.80217869 |
| 135 | MP0004947_skin_inflammation | 0.80018024 |
| 136 | MP0000747_muscle_weakness | 0.79075345 |
| 137 | MP0001879_abnormal_lymphatic_vessel | 0.79057227 |
| 138 | MP0002085_abnormal_embryonic_tissue | 0.78675884 |
| 139 | MP0001501_abnormal_sleep_pattern | 0.78660613 |
| 140 | MP0003329_amyloid_beta_deposits | 0.78588253 |
| 141 | MP0000778_abnormal_nervous_system | 0.78569978 |
| 142 | MP0004134_abnormal_chest_morphology | 0.78356267 |
| 143 | MP0005310_abnormal_salivary_gland | 0.77863620 |
| 144 | MP0005623_abnormal_meninges_morphology | 0.77339649 |
| 145 | MP0005621_abnormal_cell_physiology | 0.75505975 |
| 146 | MP0002081_perinatal_lethality | 0.75369256 |
| 147 | MP0000003_abnormal_adipose_tissue | 0.74956152 |
| 148 | MP0002557_abnormal_social/conspecific_i | 0.74894029 |
| 149 | MP0003879_abnormal_hair_cell | 0.74796113 |
| 150 | MP0002233_abnormal_nose_morphology | 0.74475365 |
| 151 | MP0001784_abnormal_fluid_regulation | 0.73993195 |
| 152 | MP0005253_abnormal_eye_physiology | 0.73378840 |
| 153 | MP0002925_abnormal_cardiovascular_devel | 0.72979606 |
| 154 | MP0003631_nervous_system_phenotype | 0.72906635 |
| 155 | MP0003755_abnormal_palate_morphology | 0.72735910 |
| 156 | MP0000427_abnormal_hair_cycle | 0.72037801 |
| 157 | MP0008789_abnormal_olfactory_epithelium | 0.71280622 |
| 158 | MP0000749_muscle_degeneration | 0.70341115 |
| 159 | MP0002998_abnormal_bone_remodeling | 0.70059984 |
| 160 | MP0000678_abnormal_parathyroid_gland | 0.69772396 |
| 161 | MP0000751_myopathy | 0.69768920 |
| 162 | MP0000013_abnormal_adipose_tissue | 0.68801187 |
| 163 | MP0005423_abnormal_somatic_nervous | 0.68138035 |
| 164 | MP0003252_abnormal_bile_duct | 0.67990191 |
| 165 | MP0006072_abnormal_retinal_apoptosis | 0.67629790 |
| 166 | MP0002168_other_aberrant_phenotype | 0.67518608 |
| 167 | MP0003115_abnormal_respiratory_system | 0.67420948 |
| 168 | MP0002752_abnormal_somatic_nervous | 0.67239924 |
| 169 | MP0003633_abnormal_nervous_system | 0.65927470 |
| 170 | MP0004145_abnormal_muscle_electrophysio | 0.64993594 |
| 171 | MP0000371_diluted_coat_color | 0.62998089 |
| 172 | MP0004381_abnormal_hair_follicle | 0.62907267 |
| 173 | MP0005670_abnormal_white_adipose | 0.62234082 |
| 174 | MP0002138_abnormal_hepatobiliary_system | 0.62098425 |
| 175 | MP0002060_abnormal_skin_morphology | 0.61940584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic microcytic anemia (HP:0004840) | 5.13914086 |
| 2 | Abnormality of the lower motor neuron (HP:0002366) | 4.83912754 |
| 3 | Hyperventilation (HP:0002883) | 4.44959141 |
| 4 | Bilateral microphthalmos (HP:0007633) | 4.40541629 |
| 5 | Ependymoma (HP:0002888) | 4.04838758 |
| 6 | Hepatoblastoma (HP:0002884) | 3.93760593 |
| 7 | Epileptic encephalopathy (HP:0200134) | 3.93260915 |
| 8 | Abnormality of the astrocytes (HP:0100707) | 3.81682362 |
| 9 | Astrocytoma (HP:0009592) | 3.81682362 |
| 10 | Febrile seizures (HP:0002373) | 3.76561893 |
| 11 | Abnormality of the fingertips (HP:0001211) | 3.29772751 |
| 12 | Resting tremor (HP:0002322) | 3.28975827 |
| 13 | Neoplasm of striated muscle (HP:0009728) | 3.16725728 |
| 14 | Macroorchidism (HP:0000053) | 3.00475430 |
| 15 | Rib fusion (HP:0000902) | 3.00286983 |
| 16 | Hypoplasia of the fovea (HP:0007750) | 2.94910317 |
| 17 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.94910317 |
| 18 | Abnormality of the corticospinal tract (HP:0002492) | 2.93512363 |
| 19 | Rhabdomyosarcoma (HP:0002859) | 2.90230181 |
| 20 | Subaortic stenosis (HP:0001682) | 2.90134374 |
| 21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.90134374 |
| 22 | Glioma (HP:0009733) | 2.89638068 |
| 23 | Atonic seizures (HP:0010819) | 2.85056351 |
| 24 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.84916530 |
| 25 | Hypopigmentation of the fundus (HP:0007894) | 2.82228425 |
| 26 | Focal seizures (HP:0007359) | 2.81908919 |
| 27 | Horizontal nystagmus (HP:0000666) | 2.64841331 |
| 28 | Neoplasm of the heart (HP:0100544) | 2.63408767 |
| 29 | Spontaneous hematomas (HP:0007420) | 2.63296813 |
| 30 | Overgrowth (HP:0001548) | 2.62840525 |
| 31 | Truncal obesity (HP:0001956) | 2.62830457 |
| 32 | Abnormality of chromosome segregation (HP:0002916) | 2.61670582 |
| 33 | Generalized hypotonia (HP:0001290) | 2.61176718 |
| 34 | Narrow palate (HP:0000189) | 2.48336853 |
| 35 | Amyotrophic lateral sclerosis (HP:0007354) | 2.48149599 |
| 36 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.46530414 |
| 37 | Excessive salivation (HP:0003781) | 2.44553566 |
| 38 | Drooling (HP:0002307) | 2.44553566 |
| 39 | Bifid tongue (HP:0010297) | 2.38894114 |
| 40 | Aortic aneurysm (HP:0004942) | 2.38561557 |
| 41 | Intestinal fistula (HP:0100819) | 2.38124480 |
| 42 | Open mouth (HP:0000194) | 2.36214054 |
| 43 | Focal motor seizures (HP:0011153) | 2.36011120 |
| 44 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.35674982 |
| 45 | Tetraplegia (HP:0002445) | 2.32571947 |
| 46 | Dialeptic seizures (HP:0011146) | 2.32333499 |
| 47 | Hyperkalemia (HP:0002153) | 2.28346761 |
| 48 | Sandal gap (HP:0001852) | 2.26233142 |
| 49 | Amblyopia (HP:0000646) | 2.24814934 |
| 50 | Malignant neoplasm of the central nervous system (HP:0100836) | 2.24560626 |
| 51 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.23805869 |
| 52 | Obstructive sleep apnea (HP:0002870) | 2.22514563 |
| 53 | Abnormality of the fovea (HP:0000493) | 2.20328837 |
| 54 | Status epilepticus (HP:0002133) | 2.17400155 |
| 55 | Neonatal hypoglycemia (HP:0001998) | 2.16536742 |
| 56 | Hyporeflexia of lower limbs (HP:0002600) | 2.15945889 |
| 57 | Dysmetric saccades (HP:0000641) | 2.15073826 |
| 58 | Insidious onset (HP:0003587) | 2.14785534 |
| 59 | Termporal pattern (HP:0011008) | 2.14785534 |
| 60 | Heterotopia (HP:0002282) | 2.13705710 |
| 61 | Abnormality of the labia minora (HP:0012880) | 2.12687892 |
| 62 | Abnormality of the salivary glands (HP:0010286) | 2.12277229 |
| 63 | Vertebral arch anomaly (HP:0008438) | 2.10367667 |
| 64 | Acute myeloid leukemia (HP:0004808) | 2.10171964 |
| 65 | Spinal cord lesions (HP:0100561) | 2.08707445 |
| 66 | Syringomyelia (HP:0003396) | 2.08707445 |
| 67 | Broad face (HP:0000283) | 2.06865350 |
| 68 | Fair hair (HP:0002286) | 2.06299213 |
| 69 | Cubitus valgus (HP:0002967) | 2.05682570 |
| 70 | Volvulus (HP:0002580) | 2.04316553 |
| 71 | Impulsivity (HP:0100710) | 2.03701350 |
| 72 | Nervous tissue neoplasm (HP:0030060) | 2.03528942 |
| 73 | Neuroectodermal neoplasm (HP:0030061) | 2.03528942 |
| 74 | Neuroepithelial neoplasm (HP:0030063) | 2.03528942 |
| 75 | Thyroid carcinoma (HP:0002890) | 2.02753645 |
| 76 | Mitral valve prolapse (HP:0001634) | 2.01855603 |
| 77 | Sensory axonal neuropathy (HP:0003390) | 2.01834803 |
| 78 | Poikilocytosis (HP:0004447) | 2.01091912 |
| 79 | Absent frontal sinuses (HP:0002688) | 1.99153738 |
| 80 | Hamartoma of the eye (HP:0010568) | 1.98952165 |
| 81 | Hand muscle atrophy (HP:0009130) | 1.98791716 |
| 82 | Papilledema (HP:0001085) | 1.98536289 |
| 83 | Difficulty running (HP:0009046) | 1.98425912 |
| 84 | Pseudobulbar signs (HP:0002200) | 1.97880090 |
| 85 | Arterial tortuosity (HP:0005116) | 1.97824088 |
| 86 | Ragged-red muscle fibers (HP:0003200) | 1.97478970 |
| 87 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.97294186 |
| 88 | Papillary thyroid carcinoma (HP:0002895) | 1.97183443 |
| 89 | Subacute progressive viral hepatitis (HP:0006572) | 1.95552786 |
| 90 | Rectovaginal fistula (HP:0000143) | 1.93977078 |
| 91 | Rectal fistula (HP:0100590) | 1.93977078 |
| 92 | Short humerus (HP:0005792) | 1.93727857 |
| 93 | Generalized hypopigmentation of hair (HP:0011358) | 1.92904080 |
| 94 | Protruding tongue (HP:0010808) | 1.91551039 |
| 95 | Absence seizures (HP:0002121) | 1.90963318 |
| 96 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.90944662 |
| 97 | Germ cell neoplasia (HP:0100728) | 1.90583285 |
| 98 | Upper motor neuron abnormality (HP:0002127) | 1.89829306 |
| 99 | Generalized tonic-clonic seizures (HP:0002069) | 1.89510071 |
| 100 | Menstrual irregularities (HP:0000858) | 1.87634841 |
| 101 | Blue irides (HP:0000635) | 1.87170761 |
| 102 | Abnormality of the ischium (HP:0003174) | 1.86988983 |
| 103 | Dyschromatopsia (HP:0007641) | 1.86496731 |
| 104 | Dysdiadochokinesis (HP:0002075) | 1.85959544 |
| 105 | Visceral angiomatosis (HP:0100761) | 1.85915928 |
| 106 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.84061700 |
| 107 | Skin tags (HP:0010609) | 1.83043768 |
| 108 | Mask-like facies (HP:0000298) | 1.82648690 |
| 109 | Postural instability (HP:0002172) | 1.82029919 |
| 110 | Scanning speech (HP:0002168) | 1.81188544 |
| 111 | Deeply set eye (HP:0000490) | 1.80272455 |
| 112 | Preauricular skin tag (HP:0000384) | 1.79520261 |
| 113 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.77417412 |
| 114 | Gaze-evoked nystagmus (HP:0000640) | 1.77141356 |
| 115 | Limb hypertonia (HP:0002509) | 1.76881410 |
| 116 | Hemangiomatosis (HP:0007461) | 1.75980548 |
| 117 | Deep philtrum (HP:0002002) | 1.75792186 |
| 118 | Vascular tortuosity (HP:0004948) | 1.75545250 |
| 119 | Complete atrioventricular canal defect (HP:0001674) | 1.75498589 |
| 120 | Freckling (HP:0001480) | 1.74364740 |
| 121 | Relative macrocephaly (HP:0004482) | 1.74257816 |
| 122 | Visual hallucinations (HP:0002367) | 1.73918114 |
| 123 | Large earlobe (HP:0009748) | 1.72827537 |
| 124 | Hemiparesis (HP:0001269) | 1.72406937 |
| 125 | Embryonal renal neoplasm (HP:0011794) | 1.72368626 |
| 126 | Ankyloglossia (HP:0010296) | 1.72010509 |
| 127 | Tented upper lip vermilion (HP:0010804) | 1.71177531 |
| 128 | Bowel incontinence (HP:0002607) | 1.71075135 |
| 129 | Failure to thrive in infancy (HP:0001531) | 1.70207352 |
| 130 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.69666297 |
| 131 | Flat acetabular roof (HP:0003180) | 1.69497279 |
| 132 | Cerebral aneurysm (HP:0004944) | 1.69348707 |
| 133 | Distal upper limb amyotrophy (HP:0007149) | 1.69320258 |
| 134 | Upper limb amyotrophy (HP:0009129) | 1.69320258 |
| 135 | Colitis (HP:0002583) | 1.69247938 |
| 136 | Impaired vibratory sensation (HP:0002495) | 1.68685008 |
| 137 | Multiple enchondromatosis (HP:0005701) | 1.68605622 |
| 138 | Action tremor (HP:0002345) | 1.68434193 |
| 139 | Exercise-induced myalgia (HP:0003738) | 1.67949423 |
| 140 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.67949201 |
| 141 | Skin nodule (HP:0200036) | 1.67441503 |
| 142 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.67416005 |
| 143 | Cone-rod dystrophy (HP:0000548) | 1.66960089 |
| 144 | Mild short stature (HP:0003502) | 1.66930975 |
| 145 | Esophageal varix (HP:0002040) | 1.66921891 |
| 146 | Tongue fasciculations (HP:0001308) | 1.66820966 |
| 147 | Hamartoma (HP:0010566) | 1.66494225 |
| 148 | Genetic anticipation (HP:0003743) | 1.65554621 |
| 149 | Hypoplastic ischia (HP:0003175) | 1.65401370 |
| 150 | Testicular atrophy (HP:0000029) | 1.65321917 |
| 151 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.64308373 |
| 152 | Medulloblastoma (HP:0002885) | 1.64303774 |
| 153 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.64106642 |
| 154 | Osteolytic defects of the hand bones (HP:0009699) | 1.64106642 |
| 155 | Shawl scrotum (HP:0000049) | 1.64024228 |
| 156 | Aneurysm (HP:0002617) | 1.63862069 |
| 157 | Dislocated radial head (HP:0003083) | 1.63542287 |
| 158 | Vaginal fistula (HP:0004320) | 1.63540894 |
| 159 | Abnormal hair whorl (HP:0010721) | 1.63012381 |
| 160 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.62687607 |
| 161 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.62679008 |
| 162 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.62591231 |
| 163 | Spastic tetraparesis (HP:0001285) | 1.62123865 |
| 164 | Tapered finger (HP:0001182) | 1.61797897 |
| 165 | Abnormal biliary tract physiology (HP:0012439) | 1.61725702 |
| 166 | Bile duct proliferation (HP:0001408) | 1.61725702 |
| 167 | Broad palm (HP:0001169) | 1.61680614 |
| 168 | Persistence of primary teeth (HP:0006335) | 1.60268826 |
| 169 | Hypoplasia of the iris (HP:0007676) | 1.60201396 |
| 170 | Increased variability in muscle fiber diameter (HP:0003557) | 1.59540604 |
| 171 | Lip pit (HP:0100267) | 1.58681630 |
| 172 | Spondylolisthesis (HP:0003302) | 1.58370020 |
| 173 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.57835838 |
| 174 | Atrioventricular canal defect (HP:0006695) | 1.57736351 |
| 175 | Cystic hygroma (HP:0000476) | 1.55594029 |
| 176 | Slow saccadic eye movements (HP:0000514) | 1.55208049 |
| 177 | Cranial hyperostosis (HP:0004437) | 1.54763253 |
| 178 | Thick eyebrow (HP:0000574) | 1.54248645 |
| 179 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.53754976 |
| 180 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.53754976 |
| 181 | T lymphocytopenia (HP:0005403) | 1.53290540 |
| 182 | Lower limb muscle weakness (HP:0007340) | 1.52843571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 6.77725504 |
| 2 | GRK5 | 3.31263336 |
| 3 | AKT3 | 3.16604286 |
| 4 | GRK6 | 2.63037246 |
| 5 | LMTK2 | 2.46394236 |
| 6 | MAP3K4 | 2.36092641 |
| 7 | PRPF4B | 2.24361903 |
| 8 | MAP2K4 | 2.18081151 |
| 9 | WNK1 | 2.11320718 |
| 10 | TYRO3 | 2.07073106 |
| 11 | ERN1 | 1.84086036 |
| 12 | SGK2 | 1.80518438 |
| 13 | NTRK3 | 1.78751979 |
| 14 | CASK | 1.75414444 |
| 15 | SGK3 | 1.73375868 |
| 16 | NEK9 | 1.68612935 |
| 17 | MAPK7 | 1.67377403 |
| 18 | GRK1 | 1.60573540 |
| 19 | TRIB3 | 1.58832322 |
| 20 | MAP3K2 | 1.57354634 |
| 21 | MAP3K13 | 1.57015892 |
| 22 | TRPM7 | 1.53946038 |
| 23 | ADRBK2 | 1.52505853 |
| 24 | NLK | 1.49881947 |
| 25 | FGFR3 | 1.41477256 |
| 26 | MAP3K7 | 1.40813502 |
| 27 | MARK2 | 1.38877520 |
| 28 | PRKG2 | 1.35248275 |
| 29 | MAP2K3 | 1.33886483 |
| 30 | KSR2 | 1.29872936 |
| 31 | MAP3K9 | 1.29186941 |
| 32 | NEK6 | 1.28285435 |
| 33 | SGK223 | 1.26254810 |
| 34 | SGK494 | 1.26254810 |
| 35 | BRD4 | 1.26217249 |
| 36 | SCYL2 | 1.25722091 |
| 37 | MAP2K7 | 1.24380408 |
| 38 | CSF1R | 1.23541771 |
| 39 | CAMKK2 | 1.23161206 |
| 40 | TTK | 1.21764672 |
| 41 | OBSCN | 1.20684294 |
| 42 | CAMK4 | 1.20453515 |
| 43 | JAK1 | 1.19160536 |
| 44 | PIK3CG | 1.18653468 |
| 45 | ALK | 1.16305710 |
| 46 | NTRK2 | 1.15391603 |
| 47 | PRKD3 | 1.13713585 |
| 48 | CAMKK1 | 1.13395247 |
| 49 | NTRK1 | 1.09937970 |
| 50 | TTN | 1.08377915 |
| 51 | TAOK3 | 1.06969252 |
| 52 | CAMK1D | 1.03597712 |
| 53 | PDGFRB | 1.03300668 |
| 54 | CAMK1G | 0.98792373 |
| 55 | INSRR | 0.97865085 |
| 56 | PRKCH | 0.97860734 |
| 57 | MTOR | 0.97135646 |
| 58 | SIK1 | 0.95729983 |
| 59 | YES1 | 0.93158514 |
| 60 | CDK6 | 0.93113177 |
| 61 | ICK | 0.91465068 |
| 62 | ACVR1B | 0.89160843 |
| 63 | FGFR4 | 0.89153539 |
| 64 | RIPK4 | 0.87164009 |
| 65 | MAP3K14 | 0.85624228 |
| 66 | PDK4 | 0.83891062 |
| 67 | PDK3 | 0.83891062 |
| 68 | PIK3CA | 0.82129863 |
| 69 | STK3 | 0.81874940 |
| 70 | PAK6 | 0.81340729 |
| 71 | HIPK2 | 0.81104863 |
| 72 | STK38 | 0.80946030 |
| 73 | CHEK2 | 0.77188493 |
| 74 | GRK7 | 0.75811851 |
| 75 | PRKAA2 | 0.75793712 |
| 76 | PRKAA1 | 0.75579923 |
| 77 | ADRBK1 | 0.74370436 |
| 78 | FGFR2 | 0.73369409 |
| 79 | RIPK1 | 0.72948923 |
| 80 | JAK2 | 0.69724920 |
| 81 | CHEK1 | 0.69438457 |
| 82 | MATK | 0.68182437 |
| 83 | CAMK1 | 0.66841824 |
| 84 | CDK3 | 0.65854698 |
| 85 | JAK3 | 0.65777008 |
| 86 | SIK2 | 0.65466142 |
| 87 | MAPK11 | 0.65011585 |
| 88 | TYK2 | 0.64982617 |
| 89 | MAP3K1 | 0.64284317 |
| 90 | AKT2 | 0.64179642 |
| 91 | MOS | 0.64090643 |
| 92 | DAPK2 | 0.63973891 |
| 93 | PTK2B | 0.63910432 |
| 94 | EPHA3 | 0.61644957 |
| 95 | MAPK10 | 0.61406381 |
| 96 | MAP3K10 | 0.61101321 |
| 97 | LATS1 | 0.60685175 |
| 98 | EPHA4 | 0.60544978 |
| 99 | MINK1 | 0.60056192 |
| 100 | PLK2 | 0.59234054 |
| 101 | STK10 | 0.58120016 |
| 102 | TSSK6 | 0.57625666 |
| 103 | MELK | 0.57413700 |
| 104 | TNK2 | 0.57093642 |
| 105 | STK11 | 0.56820047 |
| 106 | PRKCG | 0.55940469 |
| 107 | BTK | 0.55375556 |
| 108 | TGFBR2 | 0.55026360 |
| 109 | CSNK1E | 0.54805403 |
| 110 | HCK | 0.54337927 |
| 111 | RPS6KA3 | 0.53724802 |
| 112 | MET | 0.53679013 |
| 113 | PDPK1 | 0.53278509 |
| 114 | ZAP70 | 0.51553603 |
| 115 | DMPK | 0.51252742 |
| 116 | RPS6KB1 | 0.51179647 |
| 117 | RET | 0.50479697 |
| 118 | FRK | 0.50475514 |
| 119 | RAF1 | 0.50339929 |
| 120 | IRAK2 | 0.49908280 |
| 121 | RPS6KB2 | 0.49772802 |
| 122 | IRAK1 | 0.49597874 |
| 123 | DYRK1A | 0.48826441 |
| 124 | GSK3B | 0.48252898 |
| 125 | KSR1 | 0.46958292 |
| 126 | BLK | 0.46220268 |
| 127 | CDK2 | 0.45276911 |
| 128 | EEF2K | 0.45274469 |
| 129 | MARK1 | 0.44459100 |
| 130 | PDGFRA | 0.44267080 |
| 131 | ITK | 0.43827807 |
| 132 | IKBKE | 0.43483065 |
| 133 | DYRK1B | 0.43228728 |
| 134 | ATM | 0.42984627 |
| 135 | PDK1 | 0.42921649 |
| 136 | MAP3K6 | 0.42588722 |
| 137 | MAP4K1 | 0.42320343 |
| 138 | PNCK | 0.41682364 |
| 139 | MAPK14 | 0.41671150 |
| 140 | CSNK1D | 0.41132288 |
| 141 | SGK1 | 0.40398317 |
| 142 | TAOK2 | 0.40321925 |
| 143 | CDK5 | 0.40200097 |
| 144 | CDK4 | 0.39148234 |
| 145 | PKN2 | 0.38897276 |
| 146 | CDK1 | 0.38627859 |
| 147 | FGFR1 | 0.38463458 |
| 148 | CDK8 | 0.37416353 |
| 149 | PRKACB | 0.37251421 |
| 150 | MAPK8 | 0.36906212 |
| 151 | CDC42BPA | 0.36895352 |
| 152 | SIK3 | 0.35435681 |
| 153 | PAK3 | 0.34540963 |
| 154 | MAPK12 | 0.33082542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.00607834 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.85182359 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.21518319 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.13037691 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.04362232 |
| 6 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.84762459 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.83041366 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.82888208 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 1.73975320 |
| 10 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.68909449 |
| 11 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.65135974 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.60244241 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 1.57186482 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.52961317 |
| 15 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.50504866 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36895906 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.34790589 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.34679222 |
| 19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.34250179 |
| 20 | Lysine degradation_Homo sapiens_hsa00310 | 1.31636260 |
| 21 | Morphine addiction_Homo sapiens_hsa05032 | 1.31164654 |
| 22 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.30643336 |
| 23 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.29496795 |
| 24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29390484 |
| 25 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.28593588 |
| 26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.27728456 |
| 27 | Circadian entrainment_Homo sapiens_hsa04713 | 1.26046780 |
| 28 | Circadian rhythm_Homo sapiens_hsa04710 | 1.25138855 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.24809047 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.20742332 |
| 31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20566986 |
| 32 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.20170610 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.19929018 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.19351388 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16603619 |
| 36 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.15725172 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.15432371 |
| 38 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.14672047 |
| 39 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.14416546 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.13863773 |
| 41 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.13755277 |
| 42 | Prostate cancer_Homo sapiens_hsa05215 | 1.12882992 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.11875752 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.10581720 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.08104310 |
| 46 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.07626588 |
| 47 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.05572730 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05093777 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04665682 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.04209310 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02530962 |
| 52 | Adherens junction_Homo sapiens_hsa04520 | 1.01698963 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01556682 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.00881708 |
| 55 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.99783260 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99691354 |
| 57 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.97383031 |
| 58 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.96505087 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95377491 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.94869714 |
| 61 | Endometrial cancer_Homo sapiens_hsa05213 | 0.94674973 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94592084 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93839145 |
| 64 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.93647886 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 0.93053461 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92391649 |
| 67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.92030964 |
| 68 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90188726 |
| 69 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.89936992 |
| 70 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89810929 |
| 71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.89719258 |
| 72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89357086 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89008987 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88952088 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.88653372 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88211003 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87879646 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.87758884 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86407262 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.86135288 |
| 81 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.84790326 |
| 82 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.82896305 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82100215 |
| 84 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81986166 |
| 85 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78631979 |
| 86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78567881 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77164557 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76863111 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76091368 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75929386 |
| 91 | Measles_Homo sapiens_hsa05162 | 0.75636722 |
| 92 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75400726 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75080974 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.74934464 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.73062589 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73044700 |
| 97 | Hepatitis B_Homo sapiens_hsa05161 | 0.72991905 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72676819 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72067399 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71721556 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | 0.71494199 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | 0.71336880 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69530812 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69294316 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67430791 |
| 106 | Carbon metabolism_Homo sapiens_hsa01200 | 0.66604703 |
| 107 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64269324 |
| 108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64024824 |
| 109 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.63496823 |
| 110 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61193395 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61172073 |
| 112 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.61134426 |
| 113 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60555578 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60526845 |
| 115 | Phototransduction_Homo sapiens_hsa04744 | 0.60431636 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60177610 |
| 117 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59586160 |
| 118 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.58775988 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58465252 |
| 120 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58406716 |
| 121 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56933192 |
| 122 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.56850266 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56804931 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56748265 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56449029 |
| 126 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.55816347 |
| 127 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55815419 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.55603800 |
| 129 | Gap junction_Homo sapiens_hsa04540 | 0.55548282 |
| 130 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54825667 |
| 131 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53494477 |
| 132 | Influenza A_Homo sapiens_hsa05164 | 0.53307184 |
| 133 | Melanoma_Homo sapiens_hsa05218 | 0.52376949 |
| 134 | Cocaine addiction_Homo sapiens_hsa05030 | 0.52318917 |
| 135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51440227 |
| 136 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51125442 |
| 137 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48858647 |
| 138 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48814642 |
| 139 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48238909 |
| 140 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46650822 |
| 141 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46180320 |
| 142 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42504079 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41826513 |
| 144 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41804640 |

